Table 3.
Parameters | Asian patientsa | Western patientsa | p values |
---|---|---|---|
Number | 110 | 272 | |
Gender | |||
Male | 57 | 125 | 0.313 |
Female | 53 | 146 | |
Anemia (hemoglobin, ≤10 g/dL) | |||
Present | 66 | 113 | 0.025 |
Absent | 44 | 127 | |
Neutropenia (ANC ≤1.5 × 109/L) | |||
Present | 33 | 146 | <0.001 |
Absent | 77 | 89 | |
LGL lymphocytosis (≥2 × 109/L) | |||
Present | 91 | 133 | 0.732 |
Absent | 19 | 31 | |
Thrombocytopenia (≤150 × 109/L) | |||
Present | 18 | 47 | 0.218 |
Absent | 92 | 165 | |
Hepatomegaly | |||
Present | 9 | 35 | 0.109 |
Absent | 101 | 211 | |
Splenomegaly | |||
Present | 16 | 99 | <0.001 |
Absent | 94 | 147 | |
Pure red cell aplasia | |||
Present | 52 | 6 | <0.001 |
Absent | 58 | 137 | |
Rheumatoid arthritis | |||
Present | 4 | 73 | <0.001 |
Absent | 106 | 199 | |
Other autoimmune phenomena | |||
Present | 5 | 5 | 0.133 |
Absent | 105 | 267 | |
Recurrent infections | |||
Present | 3 | 81 | <0.001 |
Absent | 107 | 191 | |
Treatment outcome | |||
Cyclophosphamide-induced remission | 15/26 | 4/23 | |
Cyclosporine-induced remission | 8/19 | 11/30 | |
Fludarabine-induced remission | 8/13 | 0 | |
Remission induced by other agents | 0 | 1/10 | |
Spontaneous remission | 4 | 1 |
aThe results do not always add up to the total number of patients, because some data may be missing from the articles reviewed